Trial intelligence / Profile preview

In Vivo Imaging of Neuroinflammation in Simvastatin-Treated Schizophrenic Patients

2015-001599-23Phase 4Active

Sponsor
University Medical Center Groningen
Start
Apr 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of simvastatin in schizophrenia (2 arms), sponsored by University Medical Center Groningen. Primary endpoint: Change in [11C]PK11195 BPnd after simvastatin treatment in schizophrenic patients. Started Apr 2015; status: active.

02

Drugs

simvastatin
03

Conditions

schizophrenia

Beyond the preview

Go deeper on 2015-001599-23.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-001599-23.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call